January 19, 2006

For Immediate Release

Bone Graft Use in the U.S. and Europe Dominated by Spinal Fusions, According to January 2006 MedMarkets

The applications for bone graft substitutes include fracture alignment, oral and maxillofacial surgery, repair of bone cysts/tumors, and revision surgery. but the bulk of bone graft substitute products are used for spinal fusion procedures, which are demonstrating robust growth associated with increasing penetration of a growing demographic by effective spinal surgeries. 

"Second tier applications of bone graft substitutes include use in oral/maxillofacial and treatment of femoral, tibial and fibular fractures," notes Patrick Driscoll, Publisher of MedMarkets.  According to Driscoll, these applications combined still comprise less use of bone graft materials than does spine surgery.

The January 2006 issue of MedMarkets provides a glimpse of the competitive landscape in the U.S. and Western Europe for bone graft substitutes.  The report provides coverage of companies in this field, including Aastrom Biosciences, Abbott Spine, AlloSource, ApaTech, Baxter, Berkeley Advanced Biomaterials, Biocomposites, Biocoral, Biomet, Ceramisys, Collagen Matrix, Corin, DePuy Spine, EBI, ETEX, Exactech, Interpore Cross, IsoTis OrthoBiologics, LifeNet, Medtronic SofamorDanek, Millenium Biologix, NeuColl, Orthofix, Orthovita, OsteoBiologics, Osteotech, Regeneration Technologies, Scient’x, Smith & Nephew, Stryker Biotech, Synthes-Stratec, W. Lorenz Surgical, Wright Medical Technology, and Zimmer Spine. 

MedMarkets is available by subscription and is described here.

The bone graft substitute market is also analyzed in a separate MedMarket Diligence report described here.

MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a monthly analysis of the market implications of new medical technologies, and dedicated reports on technology markets.  Coverage in past issues is available in the MedMarkets archive pages. For additional details, contact Patrick Driscoll at email or call 949-859-3401 or toll-free (in the U.S.). 1-866-820-1357.